503B outsourcing facility
Where a compounded drug parts company with an FDA-approved one, where 503A parts company with 503B, and which accreditation programs tell them apart.
What is 503B outsourcing facility?
An FDA-registered outsourcing facility that can compound in larger volumes without a patient-specific prescription.
It is inspected by FDA and held to full cGMP, which is a materially higher bar than a 503A. For semaglutide and tirzepatide, FDA says outsourcing facilities may not compound either drug from bulk now that the shortages are over, so a seller naming a 503B source for them owes you an explanation.
Related reading: How to Verify an Online GLP-1 Pharmacy: Six Public Checks
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where 503B outsourcing facility comes up on this site
On GLP Watchdog, 503B outsourcing facility comes up in 1 research article and 1 seller review.
Research that discusses it
Seller reviews that mention it
Connected terms
Other terms under Pharmacy and drug forms
Where the evidence lives
- The full GLP-1 glossary (150 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers